Targeted Treatment can Reduce Relapse in Children With Acute Myeloid Leukemia DD4D February 11, 2014 In pediatric patients with acute myeloid leukemia (AML), the addition of a monoclonal antibody called gemtuzumab combined with standard chemotherapy